Lv1
80 积分 2022-10-19 加入
Exploratory food effect assessment in patients in early clinical development of oncology drugs
9天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia
3个月前
已完结
Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia
3个月前
已完结
An overview of regulations for bioequivalence assessment of locally acting orally inhaled drug products for the United States, Europe, Canada, and India
5个月前
已完结
Exposure-Response Relationships between the Factor B Inhibitor Iptacopan and Complement Biomarkers in Healthy Volunteers and Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH), C3 Glomerulopathy (C3G) or IgA Nephropathy (IgAN)
6个月前
已完结
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
6个月前
已完结
Cardiac Repolarization and the Safety of New Drugs Defined by Electrocardiography
7个月前
已完结
Iptacopan: First Approval
8个月前
已完结
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
8个月前
已完结
皖公网安备34019202002308
